Search results
Democrats ramp up patent fight with drug industry in bid to lower prices
Washington Post· 16 hours agoDemocrats have hit on a new tactic in their long battle with drug companies: challenge patents that...
'Outstanding' Results for Osimertinib: Stage III EGFR+ NSCLC
Medscape· 4 days agoResults from the LAURA trial will change practice once its label gets expanded, experts said at the...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 6 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Germany’s Merck Bets on AI Drug-Design Partnerships, Rules Out Acquisitions – Interview
The Wall Street Journal· 19 hours agoMerck—known as EMD Group in the U.S.— is betting on artificial-intelligence partnerships to develop...
Ionis Pharmaceuticals (IONS) Down 0.7% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 2 days agoIn the first quarter, Wainua royalty revenues were $1 million. Wainua generated sales of $5 million...
ASCO 2024: What's New in Breast Cancer Research?
Medscape· 2 days agoDrs Alexandra Thomas and Virginia Kaklamani discuss highlights in breast cancer research from the ASCO 2024 Annual Meeting.
Democrats ramp up patent fight with drug industry in bid to lower prices
Anchorage Daily News· 12 hours agoDemocrats have hit on a new tactic in their long battle with drug companies: challenge patents that...
Veeva R&D Summit: Pharma companies need a say in AI regulation
Clinical Trials Arena via Yahoo Finance· 2 days agoSenderovitz is working with partners from other pharmaceutical companies, including James...
SGLT2 Inhibitors Add to GLP-1s' Cardio, Kidney Benefits
Medscape· 5 days agoThe largest analysis to date details added effects of SGLT2 inhibitors among those with type 2...
Is Semaglutide the
Medscape· 5 days agoThere has been much hyperbole since the presentation of results from the SELECT cardiovascular outcomes trial (CVOT) at this year's European Congress on...